Optimal Balance Pharmacy

Optimal Balance Pharmacy (obprx.com) is a 503A compounding pharmacy at 2204 Cypress Creek Parkway in Houston, Texas ^[3]. It prepares patient-specific prescriptions and ships them by FedEx with syringes, alcohol wipes and reconstitution supplies, and it also runs a separate over-the-counter supplement store ^[1].

Facility & accreditation

The pharmacy describes itself as a 503A facility with a sterile clean room, and says it follows USP chapters 795, 797 and 800 for non-sterile, sterile and hazardous compounding ^[2]. It says its bulk ingredients come through PCCA, that finished preparations are tested by an independent FDA-registered laboratory, and that it is inspected by the Texas State Board of Pharmacy, the DEA, FDA and NABP’s Verified Pharmacy Program ^[2]. The Texas State Board of Pharmacy lists Optimal Balance Pharmacy LLC under licence 34829, active, first issued in August 2023, in the community sterile compounding class, with no prior disciplinary orders ^[8]. It does not claim PCAB accreditation. It is not on FDA’s list of registered 503B outsourcing facilities ^[4].

Its licensure page lists 31 states and the District of Columbia as licensed, and around 16 more as pending, including California, Ohio, Massachusetts and North Carolina ^[5]. It does not ship to every state.

What they compound

The pharmacy’s own site does not publish a product list: its specialties appear only as picture cards. The clearest record is at RxPepsDirect, whose quality page publishes the sterility and endotoxin reports from Eagle Analytical Services that the pharmacy has shared with it, and every report is addressed to Optimal Balance Pharmacy ^[9]. The 201 reports posted on 22 October 2026, from January to October 2026, include 46 batches of semaglutide with B12, 46 of tirzepatide with B12, 7 of sermorelin and 2 of glutathione, along with BPC-157, TB-500, ipamorelin, CJC-1295, GHK-Cu, NAD+, PT-141 and AOD-9604 ^[9]. Fifteen are tesamorelin, alone or mixed with ipamorelin. Tesamorelin has been regulated as a biologic since March 2020, and FDA’s notice to compounders says biologics are not eligible for 503A or 503B compounding ^[10].

Regulatory record

On 5 August 2026 the pharmacy began a voluntary recall of one lot of compounded glutathione 200 mg/mL, 30 mL multidose vials (lot LG342009076, beyond-use date 4 October 2026), 53 vials distributed nationwide, after out-of-specification results for bacterial endotoxin ^[3]. FDA classified it as a Class I recall, the category for products with a reasonable probability of serious harm, in its Enforcement Report of 9 September 2026 ^[3]. The pharmacy posts the notice, dated 19 August 2026, on its own site ^[6].

We found no FDA warning letter to Optimal Balance Pharmacy on FDA’s warning-letter portal or on FDA’s list of inspections and actions against compounders ^[7]. As a 503A pharmacy, its primary oversight is the Texas State Board of Pharmacy.

The read

A Texas 503A with a sterile licence, a clean disciplinary record with the state board and a reasonably open licensure page, but with no product list on its own site and no independent accreditation claimed. The batch reports published by RxPepsDirect show it compounding tesamorelin, which FDA does not treat as eligible for compounding. The August 2026 recall is the item to weigh: endotoxin contamination in an injectable is the kind of failure a recall exists for, and the pharmacy acted on it and published the notice. It is also the pharmacy behind RxPepsDirect, whose published batch reports are addressed to it. If a provider routes your prescription here, ask which product you are getting and check the lot against the recall.

References

1. Optimal Balance Pharmacy — home page (FedEx shipping, supplies, OTC store). (accessed 2026-10-22)
2. Optimal Balance Pharmacy — Quality Assurance (503A facility, USP 795/797/800, PCCA, independent testing, inspections). (accessed 2026-10-22)
3. FDA Enforcement Report, event 99662 — recall D-0851-2026, Optimal Balance Pharmacy, glutathione 200 mg/mL, Class I, initiated 2026-08-05, report date 2026-09-09. (accessed 2026-10-25)
4. FDA — Registered Outsourcing Facilities (503B) list, updated 2026-10-22 (Optimal Balance not listed). (accessed 2026-10-22)
5. Optimal Balance Pharmacy — Licensure (licensed and pending states). (accessed 2026-10-22)
6. Optimal Balance Pharmacy — Recall Notices (glutathione 200 mg/mL multidose vials, issued 2026-08-19). (accessed 2026-10-22)
7. FDA — Compounding: Inspections, Recalls, and other Actions. (accessed 2026-10-22)
8. Texas State Board of Pharmacy — licence 34829, Optimal Balance Pharmacy LLC. (accessed 2026-10-20)
9. RxPepsDirect — Lab Test Results (201 Eagle Analytical sterility and endotoxin reports, each addressed to Optimal Balance Pharmacy). (accessed 2026-10-22)
10. FDA — Notice to compounders: changes that affect compounding as of March 23, 2020 (biologics not eligible for 503A or 503B compounding). (accessed 2026-10-22)